Presentation + Paper
7 March 2019 What is the prospect of transcutaneous transmission of 980nm photobiomodulation therapy light to the spinal canal?
Author Affiliations +
Abstract
The clinical prospect of treating spinal cord injury by photobiomodulation therapy (PBMT) is unclear as the spinal dosimetry of transcutaneous laser application is unknown, yet essential for clinical recommendations. Light irradiances at 9 sites over an 8cm length along the thoracic to lumbar segment of the spinal canal were measured in 6 cadaver dogs using a flexible intra-spinal probe, under a surface irradiance of 3.14W/cm2. The skin transmits 4-12% of 980nm PBMT light. On-contact technique is ~5 times more efficient than off-contact technique. Transcutaneous transmission of photobiomodulatory irradiance to the spinal canal will benefit from contact-probe technique and skin-clearing approaches.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Daqing Piao, Lara A. Sypniewski, Danielle Dugut, Christian Bailey, Luis DeTaboada, and Daniel J. Burba "What is the prospect of transcutaneous transmission of 980nm photobiomodulation therapy light to the spinal canal?", Proc. SPIE 10861, Mechanisms of Photobiomodulation Therapy XIV, 108610N (7 March 2019); https://doi.org/10.1117/12.2506435
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Skin

Tissues

Spinal cord

Natural surfaces

Tissue optics

Phototherapy

Sensors

Back to Top